| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $-0.15 (Miss by $-0.27) |
| EPS GAAP Actual | $-0.15 (Miss by $-0.27) |
| Revenue Actual | $1.01703B |
| Revenue Surprise | Beat by $1017.03M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 0.77 | 46.39 | 0.72808 | 0.8368 | 1 |
| Sep 2029 | 3.06 | 11.67 | 2.87355 | 3.26751 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.97 | -0.97 | 1.01703B | 33.4% | 1017.03M |
| FQ3 2025 (Sep 2025) | -0.58 | -0.58 | 1.01175B | 31.43% | 1011.75M |
| FQ2 2025 (Jun 2025) | -1.64 | -1.64 | 1.04092B | 32.97% | 1040.92M |
| FQ1 2025 (Mar 2025) | 0.01 | 0.01 | 1.01604B | 32.29% | 1016.04M |
| FQ4 2024 (Dec 2024) | 0.55 | 0.55 | 0.677302B | 0.02% | 677.3M |
| FQ3 2024 (Sep 2024) | 0.75 | 0.75 | 0.693793B | 4.93% | 693.79M |
| FQ2 2024 (Jun 2024) | 0.89 | 0.89 | 0.697724B | -3.76% | 697.72M |
| FQ1 2024 (Mar 2024) | 0.86 | 0.86 | 0.687943B | -11.81% | 687.94M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (Jun 2030) | 0 | -- | 0 | 0 | 2 |
| FQ1 2030 (Mar 2030) | 0 | -- | 0 | 0 | 2 |
| FQ4 2029 (Dec 2029) | 0 | -- | 0 | 0 | 2 |
| FQ2 2029 (Jun 2029) | 0.8066 | -- | 0.71625 | 0.87081 | 2 |
| FQ1 2029 (Mar 2029) | 0.7751 | -- | 0.68828 | 0.8368 | 2 |
| FQ4 2028 (Oct 2028) | 0.8268 | -- | 0.8268 | 0.8268 | 10 |
| FQ3 2028 (Jul 2028) | 0.7799 | -- | 0.7799 | 0.7799 | 7 |
| FQ2 2028 (Jun 2028) | 0.7799 | -- | 0.73715 | 0.81953 | 6 |
| FQ1 2028 (Mar 2028) | 0.7663 | -- | 0.72429 | 0.80524 | 5 |
| FQ4 2027 (Dec 2027) | 0.784 | -- | 0.74102 | 0.82384 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (Jun 2030) | 0.95B | -- | 0.91B | 1.02B | 6 |
| FQ1 2030 (Mar 2030) | 0.94B | -- | 0.9B | 1B | 4 |
| FQ4 2029 (Dec 2029) | 0.91B | -- | 0.87B | 0.96B | 4 |
| FQ2 2029 (Jun 2029) | 1.17B | -- | 1.07B | 1.25B | 2 |
| FQ1 2029 (Mar 2029) | 1.15B | -- | 1.05B | 1.22B | 2 |
| FQ4 2028 (Oct 2028) | 1.06B | -- | 1.06B | 1.06B | 5 |
| FQ3 2028 (Jul 2028) | 1.04B | -- | 1.04B | 1.04B | 3 |
| FQ2 2028 (Jun 2028) | 1.03B | -- | 0.98B | 1.07B | 3 |
| FQ1 2028 (Mar 2028) | 1B | -- | 0.96B | 1.04B | 7 |
| FQ4 2027 (Dec 2027) | 0.98B | -- | 0.94B | 1.02B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.97 | -0.97 | 100% | |
| FQ3 2025 (Sep 2025) | -0.58 | -0.58 | 100% | |
| FQ2 2025 (Jun 2025) | -1.64 | -1.64 | 100% | |
| FQ1 2025 (Mar 2025) | 0.01 | 0.01 | 100% | |
| FQ4 2024 (Dec 2024) | 0.55 | 0.55 | 100% | |
| FQ3 2024 (Sep 2024) | 0.75 | 0.75 | 100% | |
| FQ2 2024 (Jun 2024) | 0.89 | 0.89 | 100% | |
| FQ1 2024 (Mar 2024) | 0.86 | 0.86 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $1.02B | $1017.03M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $1.01B | $1011.75M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.04B | $1040.92M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.02B | $1016.04M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.68B | $677.3M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.69B | $693.79M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.7B | $697.72M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.69B | $687.94M | 100% |